ABSTRACT
After large-scale radiation accidents where many individuals are suspected to be exposed to ionizing radiation, biological and physical retrospective dosimetry assays are important tools to aid clinical decision making by categorizing individuals into unexposed/minimally, moderately or highly exposed groups. Quality-controlled inter-laboratory comparisons of simulated accident scenarios are regularly performed in the frame of the European legal association RENEB (Running the European Network of Biological and Physical retrospective Dosimetry) to optimize international networking and emergency readiness in case of large-scale radiation events. In total 33 laboratories from 22 countries around the world participated in the current RENEB inter-laboratory comparison 2021 for the dicentric chromosome assay. Blood was irradiated in vitro with X rays (240 kVp, 13 mA, â¼75 keV, 1 Gy/min) to simulate an acute, homogeneous whole-body exposure. Three blood samples (no. 1: 0 Gy, no. 2: 1.2 Gy, no. 3: 3.5 Gy) were sent to each participant and the task was to culture samples, to prepare slides and to assess radiation doses based on the observed dicentric yields from 50 manually or 150 semi-automatically scored metaphases (triage mode scoring). Approximately two-thirds of the participants applied calibration curves from irradiations with γ rays and about 1/3 from irradiations with X rays with varying energies. The categorization of the samples in clinically relevant groups corresponding to individuals that were unexposed/minimally (0-1 Gy), moderately (1-2 Gy) or highly exposed (>2 Gy) was successfully performed by all participants for sample no. 1 and no. 3 and by ≥74% for sample no. 2. However, while most participants estimated a dose of exactly 0 Gy for the sham-irradiated sample, the precise dose estimates of the samples irradiated with doses >0 Gy were systematically higher than the corresponding reference doses and showed a median deviation of 0.5 Gy (sample no. 2) and 0.95 Gy (sample no. 3) for manual scoring. By converting doses estimated based on γ-ray calibration curves to X-ray doses of a comparable mean photon energy as used in this exercise, the median deviation decreased to 0.27 Gy (sample no. 2) and 0.6 Gy (sample no. 3). The main aim of biological dosimetry in the case of a large-scale event is the categorization of individuals into clinically relevant groups, to aid clinical decision making. This task was successfully performed by all participants for the 0 Gy and 3.5 Gy samples and by 74% (manual scoring) and 80% (semiautomatic scoring) for the 1.2 Gy sample. Due to the accuracy of the dicentric chromosome assay and the high number of participating laboratories, a systematic shift of the dose estimates could be revealed. Differences in radiation quality (X ray vs. γ ray) between the test samples and the applied dose effect curves can partly explain the systematic shift. There might be several additional reasons for the observed bias (e.g., donor effects, transport, experimental conditions or the irradiation setup) and the analysis of these reasons provides great opportunities for future research. The participation of laboratories from countries around the world gave the opportunity to compare the results on an international level.
Subject(s)
Chromosome Aberrations , Radioactive Hazard Release , Humans , Retrospective Studies , Radiometry/methods , Biological Assay/methods , Chromosomes , Dose-Response Relationship, RadiationABSTRACT
Objective. The goal of this work is to experimentally compare the 3D spatial and energy resolution of a semi-monolithic detector suitable for total-body positron emission tomography (TB-PET) scanners using different surface crystal treatments and silicon photomultiplier (SiPM) models.Approach. An array of 1 × 8 lutetium yttrium oxyorthosilicate (LYSO) slabs of 25.8 × 3.1 × 20 mm3separated with Enhanced Specular Reflector (ESR) was coupled to an array of 8 × 8 SiPMs. Three different treatments for the crystal were evaluated: ESR + RR + B,with lateral faces black (B) painted and a retroreflector (RR) layer added to the top face; ESR +RR, with lateral faces covered with ESR and a RR layer on the top face and; All ESR, with lateral and top sides with ESR. Additionally, two SiPM array models from Hamamatsu Photonics belonging to the series S13361-3050AE-08 (S13) and S14161-3050AS-08 (S14) have been compared. Coincidence data was experimentally acquired using a22Na point source, a pinhole collimator, a reference detector and moving the detector under study in 1 mm steps in thex- andDOI- directions. The spatial performance was evaluated by implementing a neural network (NN) technique for the impact position estimation in thex- (monolithic) andDOIdirections.Results. Energy resolution values of 16 ± 1%, 11 ± 1%, 16 ± 1%, 15 ± 1%, and 13 ± 1% were obtained for theS13-ESR + B + RR,S13-AllESR,S14-ESR + B + RR,S14-ESR + RR,andS14-AllESR, respectively. Regarding positioning accuracy, mean average error of 1.1 ± 0.5, 1.3 ± 0.5 and 1.3 ± 0.5 were estimated for thex- direction and 1.7 ± 0.8, 2.0 ± 0.9 and 2.2 ± 1.0 for theDOI- direction, for the ESR + B + RR, ESR + RR and All ESR cases, respectively, regardless of the SiPM model.Significance. Overall, the obtained results show that the proposed semi-monolithic detectors are good candidates for building TB-PET scanners.
Subject(s)
Neural Networks, Computer , Positron-Emission TomographyABSTRACT
BACKGROUND AND OBJECTIVE: Auscultation is the first technique applied to the early diagnose of any cardiovascular disease (CVD) in rural areas and poor-resources countries because of its low cost and non-invasiveness. However, it highly depends on the physician's expertise to recognize specific heart sounds heard through the stethoscope. The analysis of phonocardiogram (PCG) signals attempts to segment each cardiac cycle into the four cardiac states (S1, systole, S2 and diastole) in order to develop automatic systems applied to an efficient and reliable detection and classification of heartbeats. In this work, we propose an unsupervised approach, based on time-frequency characteristics shown by cardiac sounds, to detect and classify heartbeats S1 and S2. METHODS: The proposed system consists of a two-stage cascade. The first stage performs a rough heartbeat detection while the second stage refines the previous one, improving the temporal localization and also classifying the heartbeats into types S1 and S2. The first contribution is a novel approach that combines the dissimilarity matrix with the frame-level spectral divergence to locate heartbeats using the repetitiveness shown by the heart sounds and the temporal relationships between the intervals defined by the events S1/S2 and non-S1/S2 (systole and diastole). The second contribution is a verification-correction-classification process based on a sliding window that allows the preservation of the temporal structure of the cardiac cycle in order to be applied in the heart sound classification. The proposed method has been assessed using the open access databases PASCAL, CirCor DigiScope Phonocardiogram and an additional sound mixing procedure considering both Additive White Gaussian Noise (AWGN) and different kinds of clinical ambient noises from a commercial database. RESULTS: The proposed method outperforms the detection and classification performance of other recent state-of-the-art methods. Although our proposal achieves the best average accuracy for PCG signals without cardiac abnormalities, 99.4% in heartbeat detection and 97.2% in heartbeat classification, its worst average accuracy is always above 92% for PCG signals with cardiac abnormalities, signifying an improvement in heartbeat detection/classification above 10% compared to the other state-of-the-art methods evaluated. CONCLUSIONS: The proposed method provides the best detection/classification performance in realistic scenarios where the presence of cardiac anomalies as well as different types of clinical environmental noises are active in the PCG signal. Of note, the promising modelling of the temporal structures of the heart provided by the dissimilarity matrix together with the frame-level spectral divergence, as well as the removal of a significant number of spurious heart events and recovery of missing heart events, both corrected by the proposed verification-correction-classification algorithm, suggest that our proposal is a successful tool to be applied in heart segmentation.
Subject(s)
Heart Sounds , Signal Processing, Computer-Assisted , Algorithms , Heart , Heart Rate , Phonocardiography/methodsABSTRACT
We investigated the effect of the antioxidant lycopene supplemented into the in vitro maturation medium (TCM-199 with 20 ng/mL epidermal growth factor and 50 mg/mL gentamycin) in a heat shock (HS) model to mimic in vivo heat stress conditions. Bovine cumulus-oocyte complexes were supplemented with 0.2 µM lycopene (or not supplemented; control) under HS (40.5 °C) and non-HS (NHS; 38.5 °C) during maturation. After 22 h of maturation, we evaluated the nuclear status of the oocytes, the level of reactive oxygen species (ROS) production, and the respective blastocyst development and quality (via differential staining). Data were fitted in logistic and linear regression models, and the replicates were set as a random effect. The nuclear maturation was higher in NHS (84.0 ± 3.2%; least square mean ± standard error) than HS control (60.4 ± 4.3%; P < 0.001). Remarkably, the nuclear maturation in HS lycopene (71.7 ± 4.1%) was similar to NHS control (P = 0.7). Under HS conditions lycopene reduced ROS production (27.4 ± 4.8; relative fluorescence units (RFU)) in comparison to HS control (33.8 ± 1.8 RFU; P = 0.009). However, the ROS production in NHS lycopene (18.9 ± 2.0 RFU) was similar to NHS control (18.7 ± 1.8 RFU; P = 0.9). The cleavage rate in HS lycopene (76.1 ± 3.3%) was not lower than NHS lycopene (83.3 ± 2.5%; P > 0.1). On the day 8 of embryo development, the blastocyst rate was higher for NHS lycopene (55.2 ± 4.7%) versus NHS control (44.5 ± 4.7%; P = 0.04), but under HS the day 8 blastocyst rate was similar between control (29.9 ± 4.2%) and lycopene (32.3 ± 4.2%; P = 0.9). Lycopene supplementation increased the cell number of the embryos (total cell, trophectoderm, and inner cell mass numbers) under NHS conditions (P > 0.03). The apoptotic cell ratio was lower in lycopene (NHS and HS) versus control (NHS and HS) (P > 0.04). Lycopene has the ability to scavenge oocyte ROS and improved the cleavage rate of embryos under HS conditions. However, this could not be translated to a higher blastocyst development, which remained lower under HS. Results of our study indicate that antioxidant supplementation like lycopene during the maturation of bovine cumulus-oocyte complexes may be routinely used to improve blastocyst rate and quality under standard maturation conditions.
Subject(s)
In Vitro Oocyte Maturation Techniques , Oocytes , Animals , Blastocyst , Cattle , Dietary Supplements , Embryonic Development , Heat-Shock Response , In Vitro Oocyte Maturation Techniques/veterinary , LycopeneABSTRACT
We propose an ensemble of multilayer feedforward neural networks to estimate the 3D position of photoelectric interactions in monolithic detectors. The ensemble is trained with data generated from optical Monte Carlo simulations only. The originality of our approach is to exploit simulations to obtain reference data, in combination with a variability reduction that the network ensembles offer, thus, removing the need of extensive per-detector calibration measurements. This procedure delivers an ensemble valid for any detector of the same design. We show the capability of the ensemble to solve the 3D positioning problem through testing four different detector designs with Monte Carlo data, measurements from physical detectors and reconstructed images from the MindView scanner. Network ensembles allow the detector to achieve a 2-2.4 mm FWHM, depending on its design, and the associated reconstructed images present improved SNR, CNR and SSIM when compared to those based on the MindView built-in positioning algorithm.
Subject(s)
Brain/diagnostic imaging , Image Processing, Computer-Assisted/methods , Neural Networks, Computer , Positron-Emission Tomography , Algorithms , Calibration , Computer Simulation , Humans , Imaging, Three-Dimensional , Light , Models, Statistical , Monte Carlo Method , Optics and Photonics , Phantoms, ImagingABSTRACT
Introducción y objetivos del estudio. El infarto de miocardio posoperatorio es una complicación grave y frecuente de la cirugía cardiaca. El diagnóstico en este contexto es, en ocasiones, difícil. El objetivo de este estudio es evaluar la cinética y la precisión diagnóstica de un nuevo marcador, la heart-type fatty acid-binding protein (h-FABP), en la detección precoz de daño miocárdico en pacientes sometidos a cirugía de revascularización coronaria sin circulación extracorpórea en comparación con los biomarcadores clásicos. Materiales y métodos. Se estudiaron prospectivamente 17 pacientes consecutivos sometidos a cirugía cardiaca de revascularización sin circulación extracorpórea. Se analizaron biomarcadores de lesión de isquemia miocárdica (h-FABP, troponina, creatincinasa [CK] y CK-MB) al inicio de la cirugía (T1), inmediatamente después de la revascularización (T2), al ingreso en la UCC (T3) y después de 4 (T4), 8 (T5), 24 (T6) y 48 h (T7). Se registraron las complicaciones isquémicas perioperatorias, definidas de acuerdo con criterios electrocardiográficos, ecocardiográficos y hemodinámicos. Resultados. Los valores plasmáticos pico de la troponina se alcanzaron en T4 (2,9 ± 5,2 ng/ml) y en T5 con h-FABP (37,9 ± 55,5 ng/ml). Los valores máximos de CK y CK-MB fueron más tardíos, en T6 (741 ± 779 y 37 ± 51 U/L, respectivamente). El punto de corte obtenido para h-FABP para la detección de eventos isquémicos fue de 19 ng/ml, proporcionando una sensibilidad y especificidad del 77 y 75%, respectivamente, para el diagnóstico de la lesión isquémica perioperatoria, con un área bajo la curva ROC para h-FABP de 0,83 (IC 95% 0,6-1,0) vs. 0,63 (IC 95% 0,33-0,83) para troponina. Se alcanza este valor de corte para la h-FABP en promedio en T2 (18,9 ± 21,5 ng/ml). Conclusión. Este es el primer estudio que evalúa la cinética del biomarcador h-FABP en el perioperatorio de la cirugía de revascularización sin circulación extracorpórea, y el valor de corte establecido podría ayudar a la detección temprana de la isquemia miocárdica en este contexto (AU)
Background and goal of study. Postoperative myocardial infarction is a serious and frequent complication of cardiac surgery. Nonetheless, diagnosis in this context it is occasionally challenging. We sought to evaluate the kinetics and diagnostic accuracy of the new biomarker «heart-type fatty acid-binding protein» (h-FABP) in the early detection of myocardial injury in patients undergoing off-pump coronary artery bypass grafting, compared with classical biomarkers. Materials and methods. A prospective study was conducted on 17 consecutive patients who underwent off-pump coronary artery bypass grafting during a 2 month period. Blood samples were drawn for measurement of myocardial ischemic injury biomarkers (h-FABP, troponin, creatine kinase [CK] and CK-MB), at baseline (T1), immediate post-coronary artery bypass grafting (T2), on ICU admission (T3), and after 4 (T4), 8 (T5), 24 (T6) and 48 h (T7). Perioperative ischemic complications, defined according to electrocardiographic, echocardiographic and hemodynamic criteria, were recorded. Results. Earlier biomarkers peak plasma values occurred at T4 with troponin (2.9 ± 5.2 ng/mL), and at T5 with h-FABP (37.9 ± 55.5 ng/mL). Maximum values of CK and CK-MB occurred later, both in T6 (741 ± 779 and 37 ± 51 U/L, respectively). The optimized cut-off obtained for h-FABP was 19 ng/mL, providing a sensitivity and specificity of 77 and 75%, respectively, for diagnosis of perioperative ischemic injury, with an area under the ROC curve for h-FABP of 0.83 (95% CI 0.6-1.0) vs. 0.63 (95% CI 0.33-0.83) for troponin. This cut-off value for h-FABP is reached on average at T2 (mean value of h-FABP at T2: 18.9 ± 21.5 ng/mL). Conclusion. This is the first study evaluating the kinetics of h-FABP biomarker in perioperative off-pump coronary artery bypass grafting, and the cut-off value established could help to extend earlier detection of myocardial ischemia in this context (AU)
Subject(s)
Humans , Male , Female , Myocardial Stunning/complications , Myocardial Revascularization/methods , Myocardial Revascularization/trends , Coronary Artery Bypass, Off-Pump/methods , Coronary Artery Bypass, Off-Pump/trends , Myocardial Infarction/complications , Myocardial Infarction/diagnosis , Extracorporeal Circulation/trends , Thoracic Surgery/instrumentation , Thoracic Surgery/methods , Cardiovascular Surgical Procedures/adverse effects , Biomarkers , Prospective Studies , Electrocardiography , Myocardial Ischemia/complications , Myocardial Ischemia , TroponinABSTRACT
BACKGROUND AND GOAL OF STUDY: Postoperative myocardial infarction is a serious and frequent complication of cardiac surgery. Nonetheless, diagnosis in this context it is occasionally challenging. We sought to evaluate the kinetics and diagnostic accuracy of the new biomarker « heart-type fatty acid-binding protein ¼ (h-FABP) in the early detection of myocardial injury in patients undergoing off-pump coronary artery bypass grafting, compared with classical biomarkers. MATERIALS AND METHODS: A prospective study was conducted on 17 consecutive patients who underwent off-pump coronary artery bypass grafting during a 2 month period. Blood samples were drawn for measurement of myocardial ischemic injury biomarkers (h-FABP, troponin, creatine kinase [CK] and CK-MB), at baseline (T1), immediate post-coronary artery bypass grafting (T2), on ICU admission (T3), and after 4 (T4), 8 (T5), 24 (T6) and 48 h (T7). Perioperative ischemic complications, defined according to electrocardiographic, echocardiographic and hemodynamic criteria, were recorded. RESULTS: Earlier biomarkers peak plasma values occurred at T4 with troponin (2.9 ± 5.2 ng/mL), and at T5 with h-FABP (37.9 ± 55.5 ng/mL). Maximum values of CK and CK-MB occurred later, both in T6 (741 ± 779 and 37 ± 51 U/L, respectively). The optimized cut-off obtained for h-FABP was 19 ng/mL, providing a sensitivity and specificity of 77 and 75%, respectively, for diagnosis of perioperative ischemic injury, with an area under the ROC curve for h-FABP of 0.83 (95% CI 0.6-1.0) vs. 0.63 (95% CI 0.33-0.83) for troponin. This cut-off value for h-FABP is reached on average at T2 (mean value of h-FABP at T2: 18.9 ± 21.5 ng/mL). CONCLUSION: This is the first study evaluating the kinetics of h-FABP biomarker in perioperative off-pump coronary artery bypass grafting, and the cut-off value established could help to extend earlier detection of myocardial ischemia in this context.
Subject(s)
Coronary Artery Bypass, Off-Pump/adverse effects , Fatty Acid-Binding Proteins/blood , Myocardial Ischemia/blood , Postoperative Complications/blood , Aged , Arrhythmias, Cardiac/blood , Biomarkers , Cardiac Output, Low/blood , Cardiac Output, Low/diagnostic imaging , Cardiac Output, Low/etiology , Creatine Kinase, MB Form/blood , Echocardiography , Electrocardiography , Fatty Acid Binding Protein 3 , Female , Hemodynamics , Hospital Mortality , Humans , Length of Stay/statistics & numerical data , Male , Myocardial Ischemia/diagnostic imaging , Myocardial Ischemia/etiology , Pilot Projects , Postoperative Complications/etiology , Prospective Studies , Time Factors , Troponin I/bloodABSTRACT
Creating a sustainable network in biological and retrospective dosimetry that involves a large number of experienced laboratories throughout the European Union (EU) will significantly improve the accident and emergency response capabilities in case of a large-scale radiological emergency. A well-organised cooperative action involving EU laboratories will offer the best chance for fast and trustworthy dose assessments that are urgently needed in an emergency situation. To this end, the EC supports the establishment of a European network in biological dosimetry (RENEB). The RENEB project started in January 2012 involving cooperation of 23 organisations from 16 European countries. The purpose of RENEB is to increase the biodosimetry capacities in case of large-scale radiological emergency scenarios. The progress of the project since its inception is presented, comprising the consolidation process of the network with its operational platform, intercomparison exercises, training activities, proceedings in quality assurance and horizon scanning for new methods and partners. Additionally, the benefit of the network for the radiation research community as a whole is addressed.
Subject(s)
Biological Assay/methods , Disaster Planning/organization & administration , Radiation Injuries/prevention & control , Radiation Monitoring/methods , Radiation Protection/methods , Radioactive Hazard Release/prevention & control , Emergencies , Europe , Humans , Radiation Exposure/prevention & control , Safety Management/organization & administrationABSTRACT
Curcumin and trans-resveratrol are well-known antioxidant polyphenols with radiomodulatory properties, radioprotecting non-cancerous cells while radiosensitizing tumor cells. This dual action may be the result of their radical scavenging properties and their effects on cell-cycle checkpoints that are activated in response to radiation-induced chromosomal damage. It could be also caused by their effect on regulatory pathways with impact on detoxification enzymes, the up-regulation of endogenous protective systems, and cell-cycle-dependent processes of DNA damage. This work aims to elucidate the mechanisms underlying the dual action of these polyphenols and investigates under which conditions they exhibit radioprotecting or radiosensitizing properties. The peripheral blood lymphocyte test system was used, applying concentrations ranging from 1.4 to 140µM curcumin and 2.2 to 220µM trans-resveratrol. The experimental design focuses first on their radioprotective effects in non-cycling lymphocytes, as uniquely visualized using cell fusion-mediated premature chromosome condensation, excluding, thus, cell-cycle interference to repair processes and activation of checkpoints. Second, the radiosensitizing potential of these chemicals on the induction of chromatid breaks in cultured lymphocytes following G2-phase irradiation was evaluated by a standardized G2-chromosomal radiosensitivity predictive assay. This assay uses caffeine for G2-checkpoint abrogation and it was applied to obtain an internal control for radiosensitivity testing, which simulates conditions similar to those of the highly radiosensitive lymphocytes of AT patients. The results demonstrate for the first time the cell-cycle-dependent action of these polyphenols. When non-cycling cells are irradiated, the radioprotective properties of curcumin and trans-resveratrol are more prominent. However, when cycling cells are irradiated during G2-phase, the radiosensitizing features of these compounds are more pronounced. This observation offers a new biological basis for the mechanisms underlying the action of these polyphenols in cancer radiotherapy.
Subject(s)
Cell Cycle , Curcumin/pharmacology , Radiation-Protective Agents/pharmacology , Radiation-Sensitizing Agents/pharmacology , Stilbenes/pharmacology , Animals , CHO Cells , Cell Cycle/drug effects , Cell Fusion , Cells, Cultured , Chromatin Assembly and Disassembly/drug effects , Cricetinae , Cricetulus , G2 Phase/drug effects , Humans , Mutagenicity Tests , Radiation Tolerance/drug effects , ResveratrolABSTRACT
In Europe, a network for biological dosimetry has been created to strengthen the emergency preparedness and response capabilities in case of a large-scale nuclear accident or radiological emergency. Through the RENEB (Realising the European Network of Biodosimetry) project, 23 experienced laboratories from 16 European countries will establish a sustainable network for rapid, comprehensive and standardised biodosimetry provision that would be urgently required in an emergency situation on European ground. The foundation of the network is formed by five main pillars: (1) the ad hoc operational basis, (2) a basis of future developments, (3) an effective quality-management system, (4) arrangements to guarantee long-term sustainability and (5) awareness of the existence of RENEB. RENEB will thus provide a mechanism for quick, efficient and reliable support within the European radiation emergency management. The scientific basis of RENEB will concurrently contribute to increased safety in the field of radiation protection.
Subject(s)
Radiation Protection , Radioactive Hazard Release , Civil Defense , Emergencies , Europe , Humans , Radioactive Hazard Release/prevention & controlABSTRACT
We evaluated the genetic damage by ethanolic extract of propolis (EEP) induced to human lymphocytes which were exposed to increasing concentrations (0-2000µgml(-1)). The results indicated that EEP reduced significantly the mitotic index (MI) and proliferation index (PI) when high concentrations of EEP were used. Sister chromatid exchange (SCE) rates indicated that EEP could have genotoxic effects at high concentrations. Exposure of the cells to the amount of ethanol used as solvent did not alter either the MI and cell proliferation kinetics (CPK), or the rate of SCE. The results showed: (a) statistical increase in the percentage the cells with CAs and in the frequency of SCE at the highest concentrations, (b) a decrease in MI and in the CPK values was observed, (c) no effect was noticed in negative controls. In conclusion, it can be assumed that high concentrations of EEP have a cyto and genotoxic effect, in vitro, for human peripheral lymphocytes.
Subject(s)
Lymphocytes/drug effects , Propolis/toxicity , Cell Proliferation/drug effects , Cells, Cultured , Humans , Mitosis/drug effects , Mutagenicity Tests , Sister Chromatid Exchange/drug effectsABSTRACT
This study describes the results of the health programme implemented in the Valencian Community (Spain) to achieve an early diagnosis of Chagas disease in pregnant Latin American women and their newborns. During 2009 and 2010, 1975 women living in the health districts of three university hospitals were enrolled via midwives or at the time of delivery. Diagnosis of disease was performed using two serological tests with different antigens. Congenital infection was diagnosed by parasitological, molecular or serological methods from blood samples obtained at birth or in subsequent controls. The overall seroprevalence of Chagas infection in pregnant women from 16 different endemic countries was 11·4%. Infection was higher in those from countries in the Gran Chaco Region (Bolivia, 34·1%; Paraguay, 7·4%; Argentina, 5·3%). Eight newborn infants from Bolivian mothers had congenital Chagas which represents a vertical transmission rate of 3·7%. In conclusion, this work supports the benefits of offering an early diagnosis to pregnant women and newborns during routine prenatal healthcare.
Subject(s)
Chagas Disease/congenital , Chagas Disease/epidemiology , Infectious Disease Transmission, Vertical , Pregnancy Complications, Infectious/epidemiology , Trypanosoma cruzi/isolation & purification , Adolescent , Adult , Antibodies, Protozoan/blood , Cross-Sectional Studies , DNA, Protozoan/genetics , Enzyme-Linked Immunosorbent Assay , Female , Humans , Infant, Newborn , Male , Middle Aged , Polymerase Chain Reaction , Pregnancy , Prevalence , Spain/epidemiology , Trypanosoma cruzi/genetics , Trypanosoma cruzi/immunology , Young AdultABSTRACT
Introducción: El tratamiento de la hipertensión arterial constituye en la actualidad un pilar fundamental en las estrategias de prevención secundaria del ictus. No obstante, hoy en día no hay unanimidad en las cifras de presión arterial (PA) objetivo en prevención secundaria, y existe controversia sobre si el tratamiento antihipertensivo comprometería la perfusión cerebral de estos pacientes. El objetivo de este estudio es describir y analizar la presencia de hipotensión nocturna (HPN) en pacientes con ictus reciente a través del análisis de la monitorización ambulatoria de la PA (MAPA).Material y método: Cuarenta y ocho pacientes consecutivos que acudieron a revisión al cabo de 6 meses tras un ictus fueron incluidos en el estudio. La MAPA de 24 h se llevó a cabo mediante el monitor Spacelab 90207. Se consideraron episodios de HPN aquellos valores en los que la PAsistólica era menor de 100 mmHg. Posteriormente se compararon los pacientes con HPN frente a los que no la presentaron mediante el programa estadístico SSPS18,0. Resultados: Se estudiaron 30 varones y 18 mujeres, de edad media 68±11 años. En 26 pacientes, el 54,2%, se evidenciaron episodios de HPN. No existieron diferencias significativas entre las características demográficas, tipo de ictus y factores de riesgo entre ambos grupos (..) (AU)
Introduction: Treatment of arterial hypertension is currently a fundamental mainstay in secondary stroke prevention strategies. However, at present there is no unanimity regarding target blood pressure (BP) levels in secondary prevention. Furthermore, controversy exists on whether blood pressure lowering treatment would affect the cerebral perfusion of these patients. This study has aimed to describe and analyze the presence of nocturnal hypertension (NHT)in patients with recent stroke through the analysis of ambulatory blood pressure monitoring(ABPM).Material and method: Forty-eight consecutive patients who came for checkup 6 months after a stroke were enrolled in the study. The 24-hour ABPM was conducted using the Spacelab 90207monitor. Episodes of NHT were considered to be those in which the systolic BP was less than100 mm Hg. After, the patients with NHT were compared with those who did not have it using the SSPS 18.0 statistical program. Results: A total of 30 men and 18 women, mean age 68±11 years, were studied. Of the 26patients, evidence of NHT episodes was observed. There were no statistical differences between the demographic characteristics, type of stroke and risk factors between both groups. In relationship to the BP levels, patients with NHT had significantly lower mean 24 hour BP, mean PB with (..) (AU)
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Hypotension/diagnosis , Stroke/prevention & control , Secondary Prevention , Hypotension/etiology , Stroke/complications , Blood Pressure Monitoring, Ambulatory , Hypertension/prevention & controlABSTRACT
Radioprotection with natural products may be relevant to the mitigation of ionizing radiation-induced damage in mammalian systems; in this sense, propolis extracts have shown effects such as antioxidant, antitumoral, anti-inflammatory, and immunostimulant. We report for the first time a cytogenetic study to evaluate the radioprotective effect, in vitro, of propolis against radiation-induced chromosomal damage. Lymphocytes were cultured with increasing concentrations of ethanol extract of propolis (EEP), including 20, 40, 120, 250, 500, 750, 1000, and 2000 µg mL(-1) and then exposed to 2 Gy γ-rays. A significant and concentration-dependent decrease is observed in the frequency of chromosome aberrations in samples treated with EEP. The protection against the formation of dicentrics was concentration-dependent, with a maximum protection at 120 µg mL(-1) of EEP. The observed frequency of dicentrics is described as negative exponential function, indicating that the maximum protectible fraction of dicentrics is approximately 44%. Free radical scavenging and antioxidant activities are the mechanisms that these substances use to protect cells from ionizing radiation.
ABSTRACT
Interventional radiologists and staff members are frequently exposed to the effects of direct and scattered radiation, which undergo in deterministic effects (radiodermitis, aged skin, cataracts, telangiectasia in nasal region, vasocellular epitelioms, hands depilation) and/or stochastic ones (cancer incidence). A methodology has been proposed for estimating the radiation risk or detriment from a group of six exposed interventional radiologists of the Hospital Universitario La Fe (Valencia, Spain), which had developed general exposition symptoms attributable to deterministic effects of ionizing radiation. Equivalent doses have been periodically registered using termoluminiscence dosimeters (TLD's) and wrist dosimeters, H(p)(10) and H(p)(0.07), respectively, and estimated through the observation of translocations in lymphocytes of peripheral blood (biological methods), by extrapolating the yield of translocations to their respective dose-effect curves. The software RADRISK has been applied for estimating radiation risks in these occupational radiation exposures. The minimum and maximum average excess ratio for skin cancer has been, using wrist physical doses, of [1.03 × 10(-3), 5.06 × 10(-2)], concluding that there is not an increased risk of skin cancer incidence. The minimum and maximum average excess ratio for leukemia has been, using TLD physical doses, of [7.84 × 10(-2), 3.36 × 10(-1)], and using biological doses, of [1.40 × 10(-1), 1.51], which is considerably higher than incidence rates, showing an excess radio-induced risk of leukemia in the group under study. Finally, the maximum radiological detriment in the group, evaluated as the total number of radio-induced cancers using physical dosimetry, has been of 2.18 per 1000 person-year (skin and leukemia), and using biological dosimetry of 9.20 per 1000 PY (leukemia). As a conclusion, this study has provided an assessment of the non-deterministic effects (rate of radio-induced cancer incidence) attributable to the group under study due to their professional activity.